Merck KGaA, a leading science and technology company with 60 years of clinical experience in diabetes, announced its partnership with the International Diabetes Federation (IDF) to implement education and communications activities emphasizing the importance of preventing type 2 diabetes.
The IDF recognize diabetes overall as one of the largest global health emergencies of the 21st century and type 2 diabetes is the most common form of diabetes, estimated to contribute to up to 90% of global diabetes cases. Yet many cases of type 2 diabetes can be delayed or prevented.
“Merck shares the International Diabetes Federation’s vision of promoting diabetes care and prevention worldwide, and we are committed to helping improve the lives of people living with or at risk of Type 2 diabetes,” said Belén Garijo, M.D., member of the Executive Board and CEO Healthcare at Merck. “The IDF’s prestigious platforms, such as the online School of Diabetes and World Diabetes Day, provide a valued way for our joint education and awareness initiatives to reach and empower people with the knowledge they need in the fight against diabetes.”
The first partnership activity, available now on the IDF’s School of Diabetes website, is a CME accredited, IDF-certified healthcare professional (HCP) course about prevention of type 2 diabetes developed with an educational grant from Merck, which enables unlimited access for HCPs globally.